Review Note

Last Update: 08/23/2023 09:39 PM

Current Deck: UFS::Clinical years::Internal Medicine::Haematology

Published

Currently Published Content


Text
CML treatment involves {{c1::tyrosine kinase inhibitors::drug class?}}
Extra
  • Imatinib (Glivec®)
  • Nilotinib
  • Dasatinib
Lecture Notes
Osmosis
YouTube
Missed Questions
Pathoma
Boards and Beyond
Sketchy
Memes
OME
Additional Resources
Rosh Review
Draw It To Know It
One by one

Current Tags:

marked UFS::Semester_4::MHAE::Session_13

Pending Suggestions


No pending suggestions for this note.